Zhonghua bing li xue za zhi = Chinese journal of pathology
Nov 8, 2025
Pediatric tumors differ significantly from adult cancers, possessing unique developmental origins, histological features, and molecular genetic changes. With the rapid advancement of multi-omics technologies, such as genomics, transcriptomics, proteo...
Cancer discovery
Nov 3, 2025
Cancer research has entered a transformative era, marked by rapid advances in immunotherapy, early detection, precision oncology, and artificial intelligence that are reshaping prevention, treatment, and survivorship. To sustain momentum, the global ...
Medicine
Oct 24, 2025
This study aimed to predict mortality in cancer patients diagnosed with COVID-19 using machine learning (ML) algorithms and identify the clinical and laboratory parameters associated with mortality. Demographic, clinical, and laboratory data of cance...
Cancer research
Oct 15, 2025
UNLABELLED: tRNA-derived fragments (tRF) are a class of small noncoding RNAs that have exhibited several functions in cancer. Recent studies have shown that mutations in tRNA genes can lead to global changes in tRF expression levels and may affect tR...
Cancer research
Oct 15, 2025
UNLABELLED: Alterations to N6-methyladenosine (m6A) modifications can promote malignant progression by modulating gene expression through regulation of transcript metabolism. Quantifying the causal impact of m6A dysregulation at the population level ...
Cancer research
Oct 15, 2025
Tissue function emerges from coordinated interactions among diverse cell types, but how these interactions are structured and rewired in disease remains unclear. In a recent study, Shi and colleagues introduce CoVarNet, a computational framework that...
Cancer letters
Oct 10, 2025
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, becoming a standard approach for various tumor types. Consequently, accurately predicting their efficacy has become crucial in clinical practice. Artificial intelligence (AI) h...
Cancer discovery
Oct 6, 2025
The revolution of artificial intelligence has yet to find its way into clinical practice in oncology. We highlight eight specific challenges, focused on diagnostics, that will enable this translation once they are adequately addressed.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Oct 3, 2025
BACKGROUND: The Cancer Screening Research Network is a new clinical trials network funded by the NCI. The first Cancer Screening Research Network study, the Vanguard Study (VS), will assess the feasibility of using multi-cancer detection (MCD) tests ...
Chinese medical journal
Sep 5, 2025
Neoantigens exhibit high immunogenic potential and confer a uniqueness to tumor cells, making them ideal targets for personalized cancer immunotherapy. Neoantigens originate from tumor-specific genetic alterations, abnormal viral infections, or other...